| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
Nutlin-3 |
CCLE |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
-0.0043 |
0.9 |